O	0	3	The
O	4	10	effect
O	11	13	of
O	14	22	reusable
O	23	29	versus
B-intervention	30	40	disposable
I-intervention	41	48	draping
I-intervention	49	57	material
O	58	60	on
B-condition	61	70	infection
I-condition	71	76	rates
O	77	79	in
O	80	87	implant
O	87	88	-
O	88	93	based
O	94	100	breast
O	101	115	reconstruction
O	115	116	:
O	117	118	a
O	119	130	prospective
O	131	141	randomized
O	142	147	trial
O	147	148	.

O	149	157	Clinical
O	158	167	infection
O	168	175	remains
O	176	177	a
O	178	189	significant
O	190	197	problem
O	198	200	in
O	201	208	implant
O	208	209	-
O	209	214	based
O	215	221	breast
O	222	236	reconstruction
O	237	240	and
O	241	243	is
O	244	245	a
O	246	254	physical
O	255	258	and
O	259	268	emotional
O	269	275	strain
O	276	278	to
O	279	282	the
O	283	289	breast
O	290	304	reconstruction
O	305	312	patient
O	312	313	.

O	314	323	Bacterial
O	324	337	strikethrough
O	338	340	of
O	341	348	draping
O	349	352	and
O	353	357	gown
O	358	366	material
O	367	369	is
O	370	371	a
O	372	378	likely
O	379	385	source
O	386	388	of
O	389	398	infection
O	398	399	.

O	400	410	Strategies
O	411	413	to
O	414	420	reduce
O	421	430	infection
O	431	433	in
O	434	441	implant
O	441	442	-
O	442	447	based
O	448	454	breast
O	455	469	reconstruction
O	470	473	are
O	474	483	essential
O	484	486	to
O	487	494	improve
O	495	502	patient
O	503	511	outcomes
O	511	512	.

O	513	516	The
O	517	520	aim
O	521	523	of
O	524	528	this
O	529	534	study
O	535	537	is
O	538	540	to
O	541	550	determine
O	551	553	if
O	554	555	a
O	556	566	disposable
O	567	574	draping
O	575	581	system
O	582	584	is
O	585	593	superior
O	594	596	to
O	597	605	reusable
O	606	613	draping
O	614	623	materials
O	624	626	in
O	627	630	the
O	631	641	prevention
O	642	644	of
O	645	652	implant
O	652	653	-
O	653	658	based
O	659	665	breast
O	666	680	reconstruction
O	681	690	infection
O	690	691	.

O	692	696	This
O	697	703	single
O	703	704	-
O	704	715	institution
O	715	716	,
O	717	728	prospective
O	728	729	,
O	730	740	randomized
O	740	741	,
O	742	748	single
O	748	749	-
O	749	756	blinded
O	756	757	,
O	758	761	IRB
O	761	762	-
O	762	770	approved
O	771	776	study
O	777	785	enrolled
O	786	791	women
O	792	796	with
O	797	803	breast
O	804	810	cancer
O	811	814	who
O	815	819	were
O	820	828	eligible
O	829	832	for
O	833	840	implant
O	840	841	-
O	841	846	based
O	847	853	breast
O	854	868	reconstruction
O	868	869	.

O	870	873	The
O	874	881	primary
O	882	890	endpoint
O	891	894	was
B-outcome-Measure	895	903	clinical
I-outcome-Measure	904	913	infection
O	914	916	by
O	917	930	postoperative
O	931	934	day
O	935	937	30
O	937	938	.

O	939	948	Secondary
O	949	958	endpoints
O	959	967	included
B-outcome-Measure	968	971	all
I-outcome-Measure	972	977	other
I-outcome-Measure	978	991	complications
O	992	1003	encountered
O	1004	1014	throughout
O	1015	1018	the
O	1019	1025	follow
O	1025	1026	-
O	1026	1028	up
O	1029	1035	period
O	1036	1039	and
O	1040	1047	culture
O	1048	1052	data
O	1052	1053	.

O	1054	1065	Demographic
O	1066	1070	data
O	1071	1079	recorded
O	1080	1088	included
O	1089	1096	patient
O	1097	1100	age
O	1100	1101	,
O	1102	1106	body
O	1107	1111	mass
O	1112	1117	index
O	1117	1118	,
O	1119	1127	diabetes
O	1127	1128	,
O	1129	1136	smoking
O	1136	1137	,
O	1138	1150	chemotherapy
O	1150	1151	,
O	1152	1161	radiation
O	1161	1162	,
O	1163	1166	and
O	1167	1173	follow
O	1173	1174	-
O	1174	1176	up
O	1176	1177	.

O	1178	1188	Procedural
O	1189	1193	data
O	1194	1202	recorded
O	1203	1211	included
O	1212	1221	procedure
O	1222	1226	type
O	1226	1227	,
O	1228	1237	procedure
O	1238	1244	length
O	1244	1245	,
O	1246	1255	estimated
O	1256	1261	blood
O	1262	1266	loss
O	1266	1267	,
O	1268	1271	use
O	1272	1274	of
O	1275	1284	acellular
O	1285	1291	dermal
O	1292	1298	matrix
O	1298	1299	,
O	1300	1303	use
O	1304	1306	of
O	1307	1313	muscle
O	1314	1318	flap
O	1318	1319	,
O	1320	1323	and
O	1324	1333	inpatient
O	1334	1340	versus
O	1341	1351	outpatient
O	1352	1359	setting
O	1359	1360	.

O	1361	1365	From
O	1366	1371	March
O	1372	1376	2010
O	1377	1384	through
O	1385	1392	January
O	1393	1397	2012
O	1397	1398	,
B-total-participants	1399	1402	107
O	1403	1408	women
O	1409	1413	were
O	1414	1424	randomized
O	1425	1428	and
B-total-participants	1429	1432	102
O	1433	1442	completed
O	1443	1446	the
O	1447	1452	study
O	1452	1453	.

O	1454	1458	Five
O	1459	1467	patients
O	1468	1472	were
O	1473	1483	determined
O	1484	1487	not
O	1488	1490	to
O	1491	1493	be
O	1494	1504	candidates
O	1505	1508	for
O	1509	1523	reconstruction
O	1524	1529	after
O	1530	1543	randomization
O	1543	1544	.

O	1545	1550	There
O	1551	1555	were
B-control-participants	1556	1558	43
O	1559	1567	patients
O	1568	1570	in
O	1571	1574	the
B-control	1575	1583	Reusable
I-control	1584	1589	Group
O	1590	1593	and
B-intervention-participants	1594	1596	59
O	1597	1605	patients
O	1606	1608	in
O	1609	1612	the
O	1613	1623	Disposable
O	1624	1629	Group
O	1629	1630	.

O	1631	1636	There
O	1637	1641	were
O	1642	1644	no
O	1645	1656	significant
O	1657	1668	differences
O	1669	1671	in
O	1672	1679	patient
O	1680	1691	demographic
O	1692	1696	data
O	1696	1697	,
O	1698	1708	procedural
O	1709	1713	data
O	1713	1714	,
O	1715	1717	or
O	1718	1721	the
O	1722	1726	type
O	1727	1729	of
O	1730	1739	procedure
O	1740	1749	performed
O	1750	1757	between
O	1758	1764	groups
O	1764	1765	.

O	1766	1768	In
O	1769	1772	the
O	1773	1781	Reusable
O	1782	1787	Group
O	1787	1788	,
O	1789	1794	there
O	1795	1799	were
B-cv-bin-abs	1800	1801	5
B-outcome	1802	1812	infections
O	1813	1814	(
B-cv-bin-percent	1814	1816	12
I-cv-bin-percent	1816	1817	%
O	1817	1818	)
O	1819	1825	within
O	1826	1828	30
O	1829	1833	days
O	1834	1842	compared
O	1843	1845	to
B-iv-bin-abs	1846	1847	0
O	1848	1849	(
B-iv-bin-percent	1849	1850	0
I-iv-bin-percent	1850	1851	%
O	1851	1852	)
O	1853	1863	infections
O	1864	1866	in
O	1867	1870	the
O	1871	1881	Disposable
O	1882	1887	Group
O	1888	1889	(
O	1889	1890	P
O	1891	1892	=
O	1893	1894	0
O	1894	1895	.
O	1895	1898	012
O	1898	1899	)
O	1899	1900	.

O	1901	1906	There
O	1907	1910	was
O	1911	1913	no
O	1914	1925	significant
O	1926	1936	difference
O	1937	1939	in
B-outcome	1940	1949	secondary
I-outcome	1950	1963	complications
O	1963	1964	.

O	1965	1970	There
O	1971	1974	was
O	1975	1976	a
O	1977	1982	trend
O	1983	1986	for
B-outcome	1987	1995	positive
I-outcome	1996	2001	wound
I-outcome	2002	2010	cultures
O	2011	2012	(
B-iv-bin-percent	2012	2014	11
I-iv-bin-percent	2014	2015	%
O	2016	2018	vs
O	2018	2019	.
B-cv-bin-percent	2020	2021	3
I-cv-bin-percent	2021	2022	%
O	2022	2023	,
O	2024	2025	P
O	2026	2027	=
O	2028	2029	0
O	2029	2030	.
O	2030	2032	10
O	2032	2033	)
O	2034	2037	and
B-outcome	2038	2046	positive
I-outcome	2047	2052	drape
I-outcome	2053	2061	cultures
O	2062	2063	(
B-iv-bin-percent	2063	2065	17
I-iv-bin-percent	2065	2066	%
O	2067	2069	vs
O	2069	2070	.
B-cv-bin-percent	2070	2071	4
I-cv-bin-percent	2071	2072	%
O	2072	2073	,
O	2074	2075	P
O	2076	2077	=
O	2078	2079	0
O	2079	2080	.
O	2080	2082	08
O	2082	2083	)
O	2084	2086	in
O	2087	2095	patients
O	2096	2100	with
O	2101	2109	clinical
O	2110	2119	infection
O	2119	2120	.

O	2121	2126	There
O	2127	2131	were
O	2132	2134	no
O	2135	2146	differences
O	2147	2149	in
O	2150	2153	the
B-outcome	2154	2160	number
I-outcome	2161	2163	of
I-outcome	2164	2170	colony
I-outcome	2170	2171	-
I-outcome	2171	2178	forming
I-outcome	2179	2184	units
I-outcome	2185	2187	or
I-outcome	2188	2196	positive
I-outcome	2197	2205	cultures
O	2206	2213	between
O	2214	2220	groups
O	2220	2221	.

O	2222	2232	Disposable
O	2233	2240	draping
O	2241	2249	material
O	2250	2252	is
O	2253	2261	superior
O	2262	2264	to
O	2265	2266	a
O	2267	2275	reusable
O	2276	2283	draping
O	2284	2290	system
O	2291	2293	in
O	2294	2297	the
O	2298	2308	prevention
O	2309	2311	of
O	2312	2320	clinical
O	2321	2330	infection
O	2331	2337	within
O	2338	2341	the
O	2342	2351	immediate
O	2352	2365	postoperative
O	2366	2372	period
O	2372	2373	.

O	2374	2378	This
O	2379	2384	study
O	2385	2388	did
O	2389	2392	not
O	2393	2404	demonstrate
O	2405	2406	a
O	2407	2412	clear
O	2413	2417	link
O	2418	2425	between
O	2426	2440	intraoperative
O	2441	2448	culture
O	2449	2453	data
O	2454	2457	and
O	2458	2461	the
O	2462	2473	development
O	2474	2476	of
O	2477	2485	clinical
O	2486	2495	infection
O	2495	2496	.

O	2497	2498	A
O	2499	2509	completely
O	2510	2520	disposable
O	2521	2525	gown
O	2526	2529	and
O	2530	2537	draping
O	2538	2544	system
O	2545	2547	is
O	2548	2559	recommended
O	2560	2566	during
O	2567	2574	implant
O	2574	2575	-
O	2575	2580	based
O	2581	2587	breast
O	2588	2602	reconstruction
O	2602	2603	.
